Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

Healthcare Drug Manufacturers - Specialty & Generic
VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

VIVO Cannabis Inc. > Vivo doing all the right things...but clearly a 2021 story
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Post by skibummon Oct 04, 2020 10:04pm
236 Views
Post# 31665244

Vivo doing all the right things...but clearly a 2021 story

Vivo doing all the right things...but clearly a 2021 storylots of griping & complaining about the stock price, but face the facts. Vivo just diluted shareholder value 10% to partially settle debenture due...now has 328+M shares outstanding...and Laflamme owns a ton of them that he can dump on the market any time he wants. Vivo is still not profitable...no German licence...and Fishman has lots of other problems to deal with, one at a time. There is 50/50 chance imo that Vivo emerges as a winner in 2021...but I have a full position so I am banking on Fishman to deliver for the shareholders......1 thing Vivo did right is loan to CB2 Insite cbii/c, that was converted to 6.2M shares app .03....now valued at .24 and company showing lots of potential with telemed in US
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities